Issue 36, 2019, Issue in Progress

pH/redox sensitive nanoparticles with platinum(iv) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer

Abstract

pH/redox sensitive, dual drug loaded nanoparticles were prepared from poly(ethylene glycol)-block-poly(L-lysine) (PEG-b-PLL) for improving cancer therapy. Platinum(IV) and cis-aconitic anhydride-doxorubicin (CAD) were anchored to lysine residual amine groups of PLL to form polymer prodrug conjugates, which then self-assembled into nanoparticles with hydrophobic platinum(IV) prodrugs and CAD as the core. The nanoparticles were stable in neutral environments, but once under acidic and reductive conditions, the drugs were rapidly released. The dual-loaded nanoparticles had comparable intracellular toxicity to the regimen of combined application of free cisplatin and doxorubicin.

Graphical abstract: pH/redox sensitive nanoparticles with platinum(iv) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer

Supplementary files

Article information

Article type
Paper
Submitted
28 May 2019
Accepted
27 Jun 2019
First published
02 Jul 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 20513-20517

pH/redox sensitive nanoparticles with platinum(IV) prodrugs and doxorubicin enhance chemotherapy in ovarian cancer

G. Zhang, Y. Zhu, Y. Wang, D. Wei, Y. Wu, L. Zheng, H. Bai, H. Xiao and Z. Zhang, RSC Adv., 2019, 9, 20513 DOI: 10.1039/C9RA04034J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements